Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation

NCT07267949 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation (AF)

Interventions

DRUG: AP31969
DRUG: Placebo

Sponsor

Acesion Pharma